Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:
Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs
As of September 30, 2022 (In thousands) Total  (Level 1)  (Level 2)  (Level 3)
Assets
Cash equivalents:
Money market funds and other $ 1,050,327  $ 1,050,327  $ —  $ — 
U.S. Treasury securities 4,992  —  4,992  — 
Marketable securities:
Corporate debt securities 465,354  —  465,354  — 
Municipal securities 48,971  —  48,971  — 
Sovereign securities 5,979  —  5,979  — 
U.S. Government agency securities 76,702  76,702  —  — 
U.S. Treasury securities 427,226  408,477  18,749  — 
Equity securities 13,086  13,086  —  — 
Total cash equivalents and marketable securities(1)
2,092,637  1,548,592  544,045  — 
Other current assets:
Derivative assets 44,989  —  44,989  — 
Other non-current assets:
Executive Deferred Savings Plan 213,824  167,944  45,880  — 
Total financial assets(1)
$ 2,351,450  $ 1,716,536  $ 634,914  $ — 
Liabilities
Derivative liabilities $ (43,087) $ —  $ (43,087) $ — 
Deferred payments (2,425) —  —  (2,425)
Contingent consideration payable (23,820) —  —  (23,820)
Total financial liabilities $ (69,332) $ —  $ (43,087) $ (26,245)
________________
(1) Excludes cash of $591.1 million held in operating accounts and time deposits of $269.8 million (of which $172.8 million were cash equivalents) as of September 30, 2022.
Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows: 
Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs
As of June 30, 2022 (In thousands) Total (Level 1) (Level 2) (Level 3)
Assets
Cash equivalents:
Corporate debt securities $ 922  $ —  $ 922  $ — 
Money market funds and other 948,027  948,027  —  — 
U.S. Treasury securities 22,485  —  22,485  — 
Marketable securities:
Corporate debt securities 472,047  —  472,047  — 
Municipal securities 60,724  —  60,724  — 
Sovereign securities 5,990  —  5,990  — 
U.S. Government agency securities 91,116  91,116  —  — 
U.S. Treasury securities 348,026  344,559  3,467  — 
Equity securities 11,035  11,035  —  — 
Total cash equivalents and marketable securities(1)
1,960,372  1,394,737  565,635  — 
Other current assets:
Derivative assets 40,311  —  40,311  — 
Other non-current assets:
Executive Deferred Savings Plan 224,188  176,928  47,260  — 
Total financial assets(1)
$ 2,224,871  $ 1,571,665  $ 653,206  $ — 
Liabilities
Derivative liabilities $ (34,315) $ —  $ (34,315) $ — 
Deferred payments (2,350) —  —  (2,350)
Contingent consideration payable (23,674) —  —  (23,674)
Total financial liabilities $ (60,339) $ —  $ (34,315) $ (26,024)
________________
(1) Excludes cash of $472.8 million held in operating accounts and time deposits of $274.9 million (of which $140.7 million were cash equivalents) as of June 30, 2022.